financetom
Business
financetom
/
Business
/
Bed Bath & Beyond Acquires Kirkland's Home Brand Assets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bed Bath & Beyond Acquires Kirkland's Home Brand Assets
Sep 15, 2025 5:20 PM

08:39 AM EDT, 09/15/2025 (MT Newswires) -- Bed Bath & Beyond ( BBBY ) said Monday it has purchased Kirkland's Home trade name and related brand assets from The Brand House Collective for $10 million.

The acquisition is expected to expand Kirkland's Home into the wholesale market and set up a new recurring revenue stream, Bed Bath & Beyond ( BBBY ) said.

The company also said will it continue to receive the same collaboration fee as in the existing arrangement, which will now include revenue from the wholesale channel.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Gevo Acquires Cultivateai For Its Verity Business Unit
BRIEF-Gevo Acquires Cultivateai For Its Verity Business Unit
Sep 27, 2024
Sept 26 (Reuters) - Gevo Inc ( GEVO ): * GEVO ACQUIRES CULTIVATEAI FOR ITS VERITY BUSINESS UNIT * GEVO INC ( GEVO ) - ACQUIRES CULTIVATEAI FOR $6 MILLION IN CASH Source text for Eikon: Further company coverage: ...
Market Chatter: Intel, US Government On Track to Finalize $8.5 Billion Funding Agreement by 2024-End, FT Says
Market Chatter: Intel, US Government On Track to Finalize $8.5 Billion Funding Agreement by 2024-End, FT Says
Sep 27, 2024
04:54 AM EDT, 09/27/2024 (MT Newswires) -- Intel ( INTC ) and the US government are on track to finalize $8.5 billion in direct funding for the company before the year ends, the Financial Times reported, citing unnamed people familiar with the discussions. The preliminary terms of the funding agreement were disclosed in March. It would be the largest single...
Acumen, Lonza Extend Deal to Add Manufacturing of Sabirnetug for Alzheimer's Disease
Acumen, Lonza Extend Deal to Add Manufacturing of Sabirnetug for Alzheimer's Disease
Sep 27, 2024
08:58 AM EDT, 09/26/2024 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Thursday that it has extended its partnership with Lonza to offer drug product manufacturing for clinical and potential commercial supply from the latter's Visp, Switzerland, facility to treat Alzheimer's disease. The extended agreement requires Lonza to produce cGMP drug product of sabirnetug for the current and future...
Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints
Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints
Sep 27, 2024
08:58 AM EDT, 09/26/2024 (MT Newswires) -- Enanta Pharmaceuticals ( ENTA ) said Thursday that a phase 2a study evaluating EDP-323 in adults with respiratory syncytial virus, or RSV, met its primary and secondary endpoints. Reductions of 85% to 87% in viral load area under the curve, 97% to 98% in infectious viral load AUC, and 66% to 78% in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved